Skip to content

Universal Fixed Meal Boluses Usage in Patients With Medtronic Minimed 780G Pumps

Randomized Controlled Study of the Usage of Universal Fixed Meal Bolus Coefficients for the Control of Postprandial Hyperglycemia in the Users of Medtronic Minimed 780G Pumps

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06372392
Enrollment
20
Registered
2024-04-18
Start date
2023-10-10
Completion date
2024-12-01
Last updated
2024-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type1diabetes

Brief summary

Cross-over study of 20 pediatric patients (age 7-19) randomized to the group receiving universal fixed meal boluses coefficients (300/TDD for breakfast and 400/TDD other meal) or to the group with individualized coefficients for the period of 14 days with consecutive analysis of the results from Carelink Raport.

Interventions

DEVICEUniversal meal coefficient utilization

Usage of universal fixed meal bolus coefficients for the control of postprandial hyperglycemia compared to individualized coefficients n the users of Medtronic Minimed 780G pumps

Sponsors

Estonia Research Council
CollaboratorUNKNOWN
Tartu University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
7 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* age 7-19 * type 1 diabetes diagnosed at least 1 year ago * insulin in the dose 0,5-1,0 units/day/kg * MiniMed 780G pump usage at least 1 month.

Exclusion criteria

* Active coeliac disease * Chronic disease possible to influence diabetes treatment * Acute disease at the moment of recruitment

Design outcomes

Primary

MeasureTime frameDescription
Time in range (TIR)4 weeksComparision of TIR between groups

Secondary

MeasureTime frameDescription
TBR4 weeksComparision of TBR between groups
TAR4 weeksComparision of TAR between groups
auto-corrections %4 weeksauto-corrections % between groups
coefficient of variability4 weekscoefficient of variability between groups

Countries

Estonia

Contacts

Primary ContactAleksandr Peet, MD, PhD
aleksandr.peet@kliinikum.ee5532256
Backup ContactAleksandr Peet, MD, PhD
alekspt@hotmail.com5532256

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026